FRIDAY, Oct. 15, 2021 (HealthDay News) — Even as large numbers of U.S. nurses leave their jobs due to the stress of the pandemic, there’s been a big uptick in applications to nursing schools, the American Association of Colleges of Nursing says. Enrollment in bachelor’s, master’s and doctoral nursing programs
FRIDAY, Sept. 17, 2021 (HealthDay News) — With a special advisory panel to the U.S. Food and Drug Administration meeting Friday to decide on the need for COVID vaccine booster shots, new data shows Pfizer-BioNTech and Moderna vaccines maintaining strong levels of protection against severe illness. The data tracked the
THURSDAY, Sept. 16, 2021 (HealthDay News) — The U.S. National Institutes of Health is spending nearly $470 million to study the long-term effects of COVID-19, the agency announced Wednesday. NIH has awarded a “parent” grant to New York University (NYU) Langone Health, which will in turn make awards to more
THURSDAY, Sept. 9, 2021 (HealthDay News) — In an assertive offensive against a resurgent COVID-19 pandemic, President Joe Biden on Thursday announced sweeping new efforts at pressuring tens of millions of U.S. government workers to get vaccinated against the illness or face disciplinary action. “Many of us are frustrated with
MONDAY, Aug. 9, 2021 (HealthDay News) — All Amazon warehouse workers must wear masks as of Aug. 9, whether or not they’ve been vaccinated against COVID-19, the company says. Previously, only unvaccinated employees had to wear masks. The policy change announced Friday was made due to “the concerning spread of
WEDNESDAY, Aug. 4, 2021 (HealthDay News) — A preventive monoclonal antibody injection for people at high risk for developing severe COVID-19 after exposure to the coronavirus has been approved by the U.S. Food and Drug Administration. The first dose of Regeneron’s cocktail must be injected within 96 hours of exposure
FRIDAY, July 30, 2021 (HealthDay News) — Israelis who are over the age of 60 and fully vaccinated against COVID-19 will be offered booster shots, Prime Minister Naftali Bennett said Thursday. The announcement comes amid increasing infections and indications that the vaccine’s efficacy fades over time, the Associated Press reported.
In a HealthDay Now interview, Mabel Jong heard from experts with inside knowledge on the FDA’s controversial approval of aducanumab. First up is Dr. G. Caleb Alexander, a professor at Johns Hopkins who served on the FDA advisory committee that nearly unanimously advised against approving Biogen’s controversial new Alzheimer’s drug. Then, a conversation between Dr. Anton Porsteinsson, a principal investigator for the drug trial, and Dr. Ken Lin, a primary care physician who, like most clinicians surveyed in a new poll, has his concerns and has said he will not prescribe the new drug.